Samsung reports long-term biosimilar switching data

Samsung Bioepis Co. Ltd. disclosed long-term switching data on Wednesday from extension studies of three of the company's biosimilars of autoimmune therapies. The data are to be presented at the Annual European Congress of

Read the full 345 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE